Neoflow Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Neoflow General Information
Description
Operator of an endovascular treatment firm intended for the treatment of vasospasm in aneurysmal subarachnoid hemorrhage. The company aims to make a widely accessible simple design endovascular device for the treatment of vasospasm, enabling patients to have vasoconstriction relief by a humble local manipulation, reducing the angioplasty and systemic pharmacology risks.
Contact Information
Website
www.neoflowtech.comCorporate Office
- POB 1252
- Nazareth 1711102
- Israel
Corporate Office
- POB 1252
- Nazareth 1711102
- Israel
Neoflow Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | 01-Jan-2024 | Completed | Startup | |||
| 1. Seed Round | 01-Jan-2023 | Completed | Startup |
Neoflow Signals
Neoflow Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Arieli Group | Venture Capital | Minority |
Neoflow FAQs
-
When was Neoflow founded?
Neoflow was founded in 2023.
-
Where is Neoflow headquartered?
Neoflow is headquartered in Nazareth, Israel.
-
What is the size of Neoflow?
Neoflow has 3 total employees.
-
What industry is Neoflow in?
Neoflow’s primary industry is Surgical Devices.
-
Is Neoflow a private or public company?
Neoflow is a Private company.
-
What is Neoflow’s current revenue?
The current revenue for Neoflow is .
-
Who are Neoflow’s investors?
Arieli Group has invested in Neoflow.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process